Merck’s stock falls after disclosing government probe into asthma drug pricing – MarketWatch

Merck's stock falls after disclosing government probe into asthma drug pricing
MarketWatch
Merck & Co. Inc.'s stock dropped 1.5% in midday trade Friday, after the drug maker disclosed in a filing late Thursday that it had received a civil investigative demand from the U.S. Attorney's office. The demand requests information related to the

View full post on asthma – Google News